Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations

Huub H. van Rossum; Jocelyn Spruit; Catharina M. Korse; Froukje E. de Vries; Margot E.T. Tesselaar

doi:10.1515/cclm-2019-1111

Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations

Huub H. van Rossum^*, Jocelyn Spruit, Catharina M. Korse, Froukje E. de Vries, Margot E.T. Tesselaar

^*Corresponding author for this work

Psychiatry

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	E241-E243
Journal	Clinical Chemistry and Laboratory Medicine
Volume	58
Issue number	10
DOIs	https://doi.org/10.1515/cclm-2019-1111
Publication status	Published - 1 Oct 2020

Access to Document

10.1515/cclm-2019-1111

Cite this

@article{512399f7054e4a17ae2cd4fd39d4c05e,

title = "Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations",

keywords = "Antidepressant, Neuroendocrine tumor (net), Serotonin, Serotonin and norepinephrine reuptake inhibitor (ssri)",

author = "{van Rossum}, {Huub H.} and Jocelyn Spruit and Korse, {Catharina M.} and {de Vries}, {Froukje E.} and Tesselaar, {Margot E.T.}",

year = "2020",

month = oct,

day = "1",

doi = "10.1515/cclm-2019-1111",

language = "English",

volume = "58",

pages = "E241--E243",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "Walter de Gruyter GmbH",

number = "10",

}

Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations. / van Rossum, Huub H.; Spruit, Jocelyn; Korse, Catharina M. et al.

In: Clinical Chemistry and Laboratory Medicine, Vol. 58, No. 10, 01.10.2020, p. E241-E243.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations

AU - van Rossum, Huub H.

AU - Spruit, Jocelyn

AU - Korse, Catharina M.

AU - de Vries, Froukje E.

AU - Tesselaar, Margot E.T.

PY - 2020/10/1

Y1 - 2020/10/1

KW - Antidepressant

KW - Neuroendocrine tumor (net)

KW - Serotonin

KW - Serotonin and norepinephrine reuptake inhibitor (ssri)

UR - http://www.scopus.com/inward/record.url?scp=85078112830&partnerID=8YFLogxK

U2 - 10.1515/cclm-2019-1111

DO - 10.1515/cclm-2019-1111

M3 - Letter

C2 - 31926073

AN - SCOPUS:85078112830

VL - 58

SP - E241-E243

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 10

ER -

Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations

Access to Document

Other files and links

Cite this